What the EU is trying to do with this trade agreement is effectively slowly poison the production of affordable generic medicines in India, which has helped keep so many people alive. This trade agreement could target us as treatment providers, simply for buying generic medicines from India to treat patients in our programs.

Piero Gandini
Head of Mission for MSF in India

India has been called the “pharmacy of the developing world” because it produces a large number of high-quality, affordable generic medicines. MSF and other treatment providers also rely on Indian generic medicines to treat other diseases and conditions.

However, a free trade agreement (FTA) currently under negotiation between the European Union (EU) and India could greatly restrict the ability of Indian generic manufacturers to continue producing high-quality, affordable medicines that millions of people with HIV/AIDS and other diseases and conditions rely on to stay alive.

To learn more about the protests and the issue at hand read this briefing on the situation.

For more information also check out MSF’s Access Campaign website.

58 notes

Show

  1. exotic-fish-species-blog reblogged this from doctorswithoutborders
  2. fuckcapitalism reblogged this from blue-author
  3. stheno reblogged this from thenymreaper
  4. harsyra reblogged this from blue-author
  5. freshlykissed-blog-blog reblogged this from doctorswithoutborders
  6. girl-in-a-wheelchair reblogged this from wifestre
  7. sparksandfires-blog reblogged this from doctorswithoutborders
  8. vinegarwilliams-blog-blog reblogged this from awjila
  9. needsmoresleep reblogged this from doctorswithoutborders
  10. beccabei reblogged this from doctorswithoutborders
  11. doctorswithoutborders posted this